Table 5: Gene associations with treatment resistant hypertension that are suggestive for both AA and white participants.

Variant name Rs number Geno-typeAfrican AmericanWhite
TRH casesControlsOdds ratio (95% CI)* value*TRH casesControlsOdds ratio (95% CI)* value*

CC717 (78.8)508 (72.7)564 (44.8)662 (40.9)
MTHFR1801133CT178 (19.6)175 (25.0)0.67
(0.52–0.86)
0.002555 (44.1)751 (46.4)0.88
(0.77–0.99)
0.04
TT15 (1.7)16 (2.3)139 (11.1)207 (12.8)

AA750 (82.3)553 (79.1)345 (27.6)502 (31.2)
MMP3 5A/6A3025058 *A153 (16.8)133 (19.0)0.75
(0.57–0.98)
0.04601 (48.1)778 (48.4)1.14
(1.01–1.29)
0.03
** 8 (0.9)13 (1.9)304 (24.3)327 (20.4)

GG842 (92.7)666 (95.0)1115 (88.7)1470 (91.0)
TNF361525GA63 (6.9)34 (4.9)1.87
(1.13–3.11)
0.02139 (11.1)143 (8.9)1.44
(1.10–1.90)
0.009
AA3 (0.3)1 (0.1)3 (0.2)2 (0.1)

Odds of being a case versus control for each copy of the minor allele (additive genetic model) after adjustment for age, sex, randomized treatment group, baseline values of BMI, HDL, eGFR, SBP, and DBP, smoking status, diabetes status, and history of LVH.